Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.

van Dijken BRJ, Jan van Laar P, Li C, Yan JL, Boonzaier NR, Price SJ, van der Hoorn A.

J Neurosurg. 2018 Oct 1:1-7. doi: 10.3171/2018.5.JNS18340. [Epub ahead of print]

PMID:
30485234
2.

Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients.

Yan JL, van der Hoorn A, Larkin TJ, Boonzaier NR, Matys T, Price SJ.

J Neurosurg. 2017 Jan;126(1):234-241. doi: 10.3171/2016.1.JNS152153. Epub 2016 Apr 8.

PMID:
27058207
3.

Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.

Boonzaier NR, Larkin TJ, Matys T, van der Hoorn A, Yan JL, Price SJ.

Radiology. 2017 Jul;284(1):180-190. doi: 10.1148/radiol.2017160150. Epub 2017 Feb 27.

PMID:
28240563
4.

Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.

Kong Z, Yan C, Zhu R, Wang J, Wang Y, Wang Y, Wang R, Feng F, Ma W.

Neuroimage Clin. 2018 Jul 5;20:51-60. doi: 10.1016/j.nicl.2018.07.001. eCollection 2018. Review.

5.

Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.

Kolakshyapati M, Adhikari RB, Karlowee V, Takayasu T, Nosaka R, Amatya VJ, Takeshima Y, Akiyama Y, Sugiyama K, Kurisu K, Yamasaki F.

J Neurosurg. 2018 Mar;128(3):667-678. doi: 10.3171/2016.10.JNS161694. Epub 2017 Mar 31.

PMID:
28362236
6.
7.

Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.

Burth S, Kickingereder P, Eidel O, Tichy D, Bonekamp D, Weberling L, Wick A, Löw S, Hertenstein A, Nowosielski M, Schlemmer HP, Wick W, Bendszus M, Radbruch A.

Neuro Oncol. 2016 Dec;18(12):1673-1679. Epub 2016 Jun 13.

8.

Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.

Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T.

Eur J Radiol. 2006 Jun;58(3):394-403. Epub 2006 Mar 9.

PMID:
16527438
9.

Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma.

Krishnan AP, Karunamuni R, Leyden KM, Seibert TM, Delfanti RL, Kuperman JM, Bartsch H, Elbe P, Srikant A, Dale AM, Kesari S, Piccioni DE, Hattangadi-Gluth JA, Farid N, McDonald CR, White NS.

AJNR Am J Neuroradiol. 2017 May;38(5):882-889. doi: 10.3174/ajnr.A5099. Epub 2017 Mar 9.

10.

Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.

Chawla S, Wang S, Mohan S, Nasrallah M, Verma G, Brem S, O'Rourke DM, Wolf RL, Poptani H, Nabavizadeh SA.

J Magn Reson Imaging. 2019 Jan;49(1):184-194. doi: 10.1002/jmri.26053. Epub 2018 Apr 20.

PMID:
29676844
11.

Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors.

Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F.

Neuroradiology. 2006 Mar;48(3):150-9. Epub 2006 Feb 10.

PMID:
16470375
12.

Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.

Sauwen N, Acou M, Van Cauter S, Sima DM, Veraart J, Maes F, Himmelreich U, Achten E, Van Huffel S.

Neuroimage Clin. 2016 Sep 30;12:753-764. eCollection 2016.

13.

Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.

Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.

J Hepatol. 2013 Oct;59(4):651-7. doi: 10.1016/j.jhep.2013.05.008. Epub 2013 May 13.

PMID:
23680314
14.

Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.

Bag AK, Cezayirli PC, Davenport JJ, Gaddikeri S, Fathallah-Shaykh HM, Cantor A, Han XS, Nabors LB.

J Neurooncol. 2014 Nov;120(2):361-70. doi: 10.1007/s11060-014-1560-9. Epub 2014 Aug 7.

15.

Subventricular Zone Involvement Characterized by Diffusion Tensor Imaging in Glioblastoma.

van Dijken BRJ, Yan JL, Boonzaier NR, Li C, van Laar PJ, van der Hoorn A, Price SJ.

World Neurosurg. 2017 Sep;105:697-701. doi: 10.1016/j.wneu.2017.06.075. Epub 2017 Jun 20.

PMID:
28642175
16.

Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.

Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.

Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.

PMID:
25434389
17.

[Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction].

Feng XY, Liang J, Yin XD, Han X, Dong Q, Lü CZ.

Zhonghua Yi Xue Za Zhi. 2003 Jun 10;83(11):952-7. Chinese.

PMID:
12899795
18.

Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.

Grossman R, Shimony N, Shir D, Gonen T, Sitt R, Kimchi TJ, Harosh CB, Ram Z.

Ann Surg Oncol. 2017 Mar;24(3):794-800. doi: 10.1245/s10434-016-5635-z. Epub 2016 Oct 20.

PMID:
27766560
19.

Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.

Lee EJ, terBrugge K, Mikulis D, Choi DS, Bae JM, Lee SK, Moon SY.

AJR Am J Roentgenol. 2011 Jan;196(1):71-6. doi: 10.2214/AJR.10.4752.

PMID:
21178049
20.

Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab.

Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H, Matsuda M, Matsumura A.

Acta Neurochir Suppl. 2013;118:185-9. doi: 10.1007/978-3-7091-1434-6_34.

PMID:
23564129

Supplemental Content

Support Center